Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Xtant Medical Stock Quote

Xtant Medical (NYSEMKT: XTNT)

$0.84
(6.7%)
$0.05
Price as of April 18, 2024, 4:00 p.m. ET

Xtant Medical Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
XTNT +36.80% -72.09% -22.51% -100%
S&P +20.62% +72.50% +11.51% +388%

Xtant Medical Company Info

Xtant Medical Holdings, Inc. designs, and develops orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoSTX, Certex Spinal Fixation System, Axle Interspinous Fusion System, and Calix. The company was founded in 2006 and is headquartered in Belgrade, MT.

News & Analysis

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.